$BCRX News Article - BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months https://marketwirenews.com/news-releases/bioc...33630.html
(0)
(0)
BioCryst Pharmaceuticals Inc. (BCRX) Stock Research Links